Matches in SemOpenAlex for { <https://semopenalex.org/work/W2328931461> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2328931461 endingPage "1289" @default.
- W2328931461 startingPage "1275" @default.
- W2328931461 abstract "Antiepileptic drugs (AEDs) cover a broad spectrum of pathological conditions ranging from seizures following congenital or acquired brain disorders to behavioural and psychiatric disorders and recently neuropathic pain. The need for novel antiepileptics raises from the expanding field of indications as well as from the fact, that special seizure types are refractory to common AEDs. In addition, many of the conventional antiepileptic drugs exhibit an unfavourable side-effect profile. Since there is growing evidence, that NMDA receptor activation might play a crucial role in epilepsy, NMDA receptor antagonists have become compounds of interest in preventing and treating seizures. This review focuses on NMDA receptor antagonistic compounds, which are already in use for the treatment of epileptic seizures (i. e. MgSO4, felbamate) and compounds in clinical trials (i. e. remacemide, ADCI). Further interest is put on NMDA antagonists in preclinical and biological testing (memantine, dizocilpine, conantokins, Co101244/PD174494, ifenprodil, arcaine, L-701,324, eliprodil, CGP40116, LY235959, LY233053, MRZ2/576, LU73068, 4-Cl-KYN). Some of the latter compounds are predominantely of academic interest (i. e. 4-Cl-KYN), others (i. e. dizocilpine, LY235959, LY233053) might be of therapeutical value when combined with conventional AEDs. In order to reduce adverse effects in antiepileptic medication using NMDA antagonists, special interest will be focused on subtype selective compounds. In this respect, Co101244, a novel potent and selective NR1/2B NMDA receptor antagonist might be a lead for therapeutically promising compounds." @default.
- W2328931461 created "2016-06-24" @default.
- W2328931461 creator A5010723851 @default.
- W2328931461 creator A5086411867 @default.
- W2328931461 date "2001-09-01" @default.
- W2328931461 modified "2023-09-30" @default.
- W2328931461 title "The NMDA Receptor Complex: A Promising Target for Novel Antiepileptic Strategies" @default.
- W2328931461 doi "https://doi.org/10.2174/0929867013372328" @default.
- W2328931461 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11562266" @default.
- W2328931461 hasPublicationYear "2001" @default.
- W2328931461 type Work @default.
- W2328931461 sameAs 2328931461 @default.
- W2328931461 citedByCount "82" @default.
- W2328931461 countsByYear W23289314612012 @default.
- W2328931461 countsByYear W23289314612013 @default.
- W2328931461 countsByYear W23289314612014 @default.
- W2328931461 countsByYear W23289314612015 @default.
- W2328931461 countsByYear W23289314612016 @default.
- W2328931461 countsByYear W23289314612017 @default.
- W2328931461 countsByYear W23289314612018 @default.
- W2328931461 countsByYear W23289314612020 @default.
- W2328931461 countsByYear W23289314612021 @default.
- W2328931461 countsByYear W23289314612022 @default.
- W2328931461 countsByYear W23289314612023 @default.
- W2328931461 crossrefType "journal-article" @default.
- W2328931461 hasAuthorship W2328931461A5010723851 @default.
- W2328931461 hasAuthorship W2328931461A5086411867 @default.
- W2328931461 hasConcept C118552586 @default.
- W2328931461 hasConcept C126322002 @default.
- W2328931461 hasConcept C15744967 @default.
- W2328931461 hasConcept C169760540 @default.
- W2328931461 hasConcept C170493617 @default.
- W2328931461 hasConcept C2775858608 @default.
- W2328931461 hasConcept C2777836312 @default.
- W2328931461 hasConcept C2778186239 @default.
- W2328931461 hasConcept C2779484449 @default.
- W2328931461 hasConcept C2780376555 @default.
- W2328931461 hasConcept C2781011581 @default.
- W2328931461 hasConcept C67018056 @default.
- W2328931461 hasConcept C71924100 @default.
- W2328931461 hasConcept C98274493 @default.
- W2328931461 hasConceptScore W2328931461C118552586 @default.
- W2328931461 hasConceptScore W2328931461C126322002 @default.
- W2328931461 hasConceptScore W2328931461C15744967 @default.
- W2328931461 hasConceptScore W2328931461C169760540 @default.
- W2328931461 hasConceptScore W2328931461C170493617 @default.
- W2328931461 hasConceptScore W2328931461C2775858608 @default.
- W2328931461 hasConceptScore W2328931461C2777836312 @default.
- W2328931461 hasConceptScore W2328931461C2778186239 @default.
- W2328931461 hasConceptScore W2328931461C2779484449 @default.
- W2328931461 hasConceptScore W2328931461C2780376555 @default.
- W2328931461 hasConceptScore W2328931461C2781011581 @default.
- W2328931461 hasConceptScore W2328931461C67018056 @default.
- W2328931461 hasConceptScore W2328931461C71924100 @default.
- W2328931461 hasConceptScore W2328931461C98274493 @default.
- W2328931461 hasIssue "11" @default.
- W2328931461 hasLocation W23289314611 @default.
- W2328931461 hasLocation W23289314612 @default.
- W2328931461 hasOpenAccess W2328931461 @default.
- W2328931461 hasPrimaryLocation W23289314611 @default.
- W2328931461 hasRelatedWork W1996216954 @default.
- W2328931461 hasRelatedWork W2013124619 @default.
- W2328931461 hasRelatedWork W2025497070 @default.
- W2328931461 hasRelatedWork W2025992509 @default.
- W2328931461 hasRelatedWork W2039071842 @default.
- W2328931461 hasRelatedWork W2071640504 @default.
- W2328931461 hasRelatedWork W2085211759 @default.
- W2328931461 hasRelatedWork W2108999942 @default.
- W2328931461 hasRelatedWork W2328931461 @default.
- W2328931461 hasRelatedWork W4249700339 @default.
- W2328931461 hasVolume "8" @default.
- W2328931461 isParatext "false" @default.
- W2328931461 isRetracted "false" @default.
- W2328931461 magId "2328931461" @default.
- W2328931461 workType "article" @default.